Marlowe Regulatory News (MRL)

14 January 2022

Marlowe plc

("Marlowe" or the "Company")

Exercise of Share Options under 2020 SAYE Scheme

The Company announces that, as a result of an exercise of employee share options under the Marlowe 2020 SAYE Scheme, application has been made for 1,336 new ordinary shares of 50 pence each in the Company (the "New Ordinary Shares") to be admitted to trading on AIM.

The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 20 January 2022.

Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 82,640,837 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 82,640,837.

For further information:

About Marlowe plc

Marlowe is a UK leader in business critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 15% of Britain's commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.